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T he simultaneous operation of aortic arch repair (AAR)and coronary artery bypass grafting has been associatedwith considerable operative morbidity and mortality.1-3This combined procedure has been considered inevita-
ble, with prolonged myocardial ischemia and cardiopulmonary
bypass (CPB) time, which are significant risk factors for adverse
outcome in aortic arch surgery.2 Appropriate myocardial protec-
tion is also mandatory to avoid perioperative myocardial failure.
Recent technical improvements in off-pump coronary artery
bypass (OPCAB) encouraged us to introduce OPCAB into this
simultaneous operation to minimize the period of myocardial
ischemia and CPB for improved surgical outcome in these patients
with multiorgan arteriosclerosis.
Patients
From November 1999 through June 2004, 16 patients underwent
the simultaneous operation of OPCAB and AAR. There were 15
(94%) male patients and 1 female patient, with an average age of
70  7 years (range, 62-80 years). All patients had atherosclerotic
aortic arch aneurysm and major coronary artery stenosis, with
comorbidities such as hypertension (100%), left ventricular hyper-
trophy (56%), and old cerebral infarction (63%).
Operative Techniques
Time course of the combined procedure. For better un-
derstanding of the combined procedure of coronary artery bypass
grafting and AAR, the comparison of time course in the conven-
tional procedure and OPCAB with AAR is presented in Figure 1.
OPCAB. After median sternotomy, a deep pericardial suture
and heart retractor (Starfish; Medtronic Inc, Minneapolis, Minn)
were used for the exposure of the coronary arteries. The coronary
artery anastomosis was constructed with a running 7-0 monofila-
ment suture, with the aid of an Octopus stabilizer (Medtronic Inc),
a CO2 blower, and an intraluminal shunt.4
AAR with antegrade cerebral perfusion. CPB was estab-
lished with right atrial drainage and artery perfusion through the
bilateral axillary and femoral artery. During the core cooling and
aortic crossclamping periods, the antegrade cold blood cardiople-
gic solution was delivered through the aortic root, as well as the
preattached coronary artery bypass grafts. The proximal end of the
coronary artery graft was attached on the ascending aorta, followed
by intermittent antegrade and retrograde delivery of cardioplegic
solution. The open distal anastomosis with a 4-branched Dacron
graft was performed under antegrade cerebral perfusion through
the left carotid and bilateral axillary arteries at a body temperature
of 25°C. Distal body perfusion was restarted through the branched
graft. After the proximal graft–ascending aorta anastomosis, the
arch graft was declamped to cease the myocardial ischemia. The
left subclavian, left common carotid, and brachiocephalic arteries
were reattached to the branched graft, followed by weaning from
CPB.
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TO COME?
Figure 1. Time course in the combined procedure of coronary
artery revascularization and AAR. A, Coronary artery bypass graft-
ing (CABG) on the arrested heart and AAR. B, OPCAB and AAR.
Note the period of CPB and aortic crossclamping (myocardial
ischemia time) are shorter in B than in A.
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Results
The patient’s intraoperative and postoperative data are shown in
Table 1. Five (31%) patients had multivessel coronary artery
bypasses. Fifteen (94%) patients had a CPB time of shorter than
300 minutes. All patients had a myocardial ischemic time of
shorter than 180 minutes. There was no perioperative myocardial
failure, new myocardial infarction, or permanent neurologic dys-
function. The median intensive care unit stay was 4 days. There
was no early (30 days) operative mortality. One patient with
chronic renal failure died of gastrointestinal bleeding during he-
modialysis, resulting in an in-hospital mortality of 6%.
Discussion
The introduction of OPCAB to AAR with coronary artery revas-
cularization has 3 major advantages.
First, this novel technique can minimize the myocardial isch-
emic time to decrease the risk of postoperative myocardial failure
when compared with the conventional operation, in which distal
coronary anastomoses are produced on the arrested heart during
myocardial ischemia.
Second, the cardioplegic solution can be delivered through the
preattached coronary artery bypass grafts into the myocardium,
which is supplied by stenotic or obstructed coronary arteries.
Superior myocardial protection is mandatory for the hypertrophied
hearts, as frequently seen in these patients with longstanding
hypertension.
Third, this technique can minimize the CPB time, as seen in
Figure 1. Recently, Kazui and colleagues,5 using multivariate
analysis, reported that a CPB time of longer than 300 minutes is an
independent determinant of in-hospital mortality in total arch
replacement with antegrade selective cerebral perfusion. In our
study, the longest CPB time was 302 minutes in a patient with
triple-vessel disease. All the other patients (94%) had CPB times
of shorter than 300 minutes, decreasing the risk of morbidity, such
as prolonged respiratory support and intensive care unit stay or
neurologic dysfunction. We speculate that this new technique
would be more beneficial for patients with multivessel coronary
artery disease who require longer periods of coronary artery anas-
tomosis.
In conclusion, our preliminary experience demonstrated that
the introduction of OPCAB to the simultaneous operation of AAR
and coronary revascularization can be performed feasibly and with
a satisfactory surgical outcome in these elderly patients with the
complication of multiorgan atherosclerotic lesions.
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TABLE 1. Intraoperative and postoperative data (n  16)
Variables
No. of coronary artery anastomoses 1.5 0.8 (13)
Type of graft: SVG/RA/ITA 11/10/1
Cardiopulmonary bypass time (min) 243 35 (187303)
300 min 1 (6%)
Myocardial ischemic time (min) 136 24 (99178)
180 min 0
Lowest rectal temperature (°C) 23 2 (1925)
Perioperative myocardial infarction 0
Peak CK-MB (U/L) 36 20 (1280)
Early graft patency 96% (22/23)
Prolonged respiratory support (3 d) 5 (31%)
Neurologic dysfunction
Transient 3 (19%)
Permanent 0
Early (30 d) death 0
In-hospital death 1 (6%)
Data are expressed as means  SD (range) unless otherwise stated. SVG,
Saphenous vein graft; RA, radial artery; ITA, internal thoracic artery;
CK-MB, creatinine kinase myocardial band.
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